Filing Details
- Accession Number:
- 0001477449-24-000106
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-02 16:05:53
- Reporting Period:
- 2024-05-01
- Accepted Time:
- 2024-05-02 16:05:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1477449 | Teladoc Health Inc. | TDOC | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 043705970 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1936444 | Willem Michael Waters | C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-05-01 | 11,319 | $0.00 | 70,674 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-05-02 | 5,793 | $12.69 | 64,881 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2024-05-01 | 11,319 | $0.00 | 11,319 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
56,599 | No | 4 | M | Direct |
Footnotes
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
- On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.